Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retinoid antagonists]

H Umemiya1, H Kagechika, H Fukasawa

  • 1Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|December 1, 1996
PubMed
Summary

Retinoids regulate cell functions via nuclear receptors. Novel compounds like LE135 act as antagonists, while HX600 shows synergistic effects, possibly involving other nuclear receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aggregated chromosomes/chromatin transfer: a novel approach for mitochondrial replacement with minimal mitochondrial carryover: the implications of mouse experiments for human aggregated chromosome transfer.

Molecular human reproduction·2023
Same author

Research Note: Expression of IGF-1 and IGF-1 receptor proteins in skeletal muscle fiber types in chickens with hepatic fibrosis.

Poultry science·2022
Same author

Morphological characterization of small hepatocytes after bile duct ligation in chicken.

Poultry science·2018
Same author

HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage.

Brain, behavior, and immunity·2018
Same author

Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients.

European journal of clinical nutrition·2016
Same author

Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells.

Cell death & disease·2015

Area of Science:

  • Molecular Endocrinology
  • Cell Biology
  • Drug Discovery

Context:

  • Retinoids, including retinoic acid, are crucial regulators of vital biological processes such as cell differentiation, proliferation, and embryonic development in vertebrates.
  • These functions are mediated through the binding and activation of specific nuclear receptors, primarily retinoic acid receptors (RARs) and retinoid X receptors (RXRs).
  • Understanding these interactions is key to developing targeted therapies for various diseases.

Purpose:

  • To investigate the structure-activity relationships of retinoid antagonists and identify novel compounds with distinct biological activities.
  • To explore the mechanism of action for compounds like LE135 and HX600, which exhibit antagonistic and synergistic effects on retinoid signaling pathways, respectively.
  • To elucidate the potential involvement of additional nuclear receptors or cofactors in mediating retinoid synergism.

Summary:

  • LE135 is a RAR beta-selective retinoid antagonist, with analogs LE540 and LE550 demonstrating enhanced antagonistic potency in HL-60 assays.
  • HX600, an isomer of LE135, exhibits synergistic activity with retinoids, suggesting a mechanism beyond simple RXR activation or RAR/RXR heterodimer potentiation.
  • The unique biological profile of HX600 indicates a potential role for other nuclear receptors or cofactors in retinoid synergism, expanding our understanding of retinoid signaling.

Impact:

  • Identifies specific retinoid antagonists (LE135, LE540, LE550) with potential therapeutic applications.
  • Reveals a novel synergistic compound (HX600) that may modulate retinoid signaling through previously uncharacterized pathways.
  • Provides a foundation for further research into the complex interplay of nuclear receptors and cofactors in retinoid-mediated biological responses.

Related Experiment Videos